REN and metabolic dysfunction-associated steatotic liver disease: Although several studies indicated beneficial effects of renin-angiotensin system blockers on histological fibrosis progression in NAFLD, current evidence is insufficient to recommend renin-angiotensin system blockers only for the purpose of managing fibrosis in NAFLD patients [167].